PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
Titel:
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
Auteur:
Koren, Michael J Descamps, Olivier Hata, Yoshiki Hengeveld, Ellen Margo Hovingh, G Kees Ikonomidis, Ignatios Radu Juul Jensen, Maria D Langbakke, Irene Hedelund Martens, Fabrice M A C Søndergaard, Anette Luther Witkowski, Adam Koenig, Wolfgang